Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

9

Number of overlapping holdings

33.3%

% of MEDX's 32 holdings also in PJP

37.5%

% of PJP's 24 holdings also in MEDX

Overlap by Weight
Sector Drift (MEDX minus PJP)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in PJP
Overlap
ELI LILLY & CO 11.7% 6.7% 6.7%
ABBVIE INC 6.2% 5.9% 5.9%
AMGEN INC 5.2% 6.4% 5.2%
JOHNSON & JOHNSON 5.1% 5.7% 5.1%
PFIZER INC 4.6% 5.2% 4.6%

Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PJP
NOVARTIS AG-ADR 5.5%
BRISTOL-MYERS SQUIBB CO 5.1%
ELI LILLY & CO 5.0%
ASTRAZENECA PLC-SPONS ADR 4.7%
CRISPR THERAPEUTICS AG 4.4%
IONIS PHARMACEUTICALS, INC. 3.6%
SANOFI-AVENTIS-ADR 3.4%
ALKERMES PLC 3.3%
ALNYLAM PHARMACEUTICALS INC 2.7%
EDITAS MEDICINE, INC. 1.9%
MEDX Underweight Relative to PJP
ABBOTT LABORATORIES -6.1%
AMPHASTAR PHARMACEUTICALS INC -3.9%
UNITED THERAPEUTICS CORP -3.8%
TARO PHARMACEUTICAL INDUS -3.8%
PRESTIGE BRANDS HOLDINGS INC -3.7%
LIGAND PHARMACEUTICALS-CL B -3.4%
JAZZ PHARMACEUTICALS PLC -3.3%
SUPERNUS PHARMACEUTICALS INC -3.2%
GERON CORP -3.2%
VALEANT PHARMACEUTICALS INT'L -3.1%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY